Actively Recruiting
Clinical Trial on Deprescribing Associated With a Psychoeducational Program Using Virtual Reality for Patients With Chronic Pain and Central Sensitization
Led by Badalona Serveis Assistencials · Updated on 2025-05-14
72
Participants Needed
4
Research Sites
94 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial evaluates the effectiveness of the REDOCVR program, an interdisciplinary, psychoeducational intervention designed to support deprescribing of chronic pain medications in primary care. REDOCVR integrates group-based education, physical activation, and emotional regulation techniques, enhanced by immersive virtual reality (VR) content that reinforces therapeutic learning and engagement. Rather than functioning as a standalone tool, VR serves as a complementary catalyst within a person-centered, clinician-guided framework. This randomized trial adds a structured medication tapering component and runs in parallel with a complementary pilot study (ClinicalTrials.gov Identifier: NCT06361706), which evaluates the base REDOCVR program without supervised deprescribing. Both protocols are active and jointly contribute to an adaptive, scalable model of chronic pain care in primary care settings. Outcomes include medication use, emotional well-being, anxiety and depression, quality of life, and usability of VR.
CONDITIONS
Official Title
Clinical Trial on Deprescribing Associated With a Psychoeducational Program Using Virtual Reality for Patients With Chronic Pain and Central Sensitization
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults (≥18 years) diagnosed with chronic non-cancer pain persisting for at least 3 months
- Assigned to one of the participating primary care centers
- Presence of central sensitization symptoms, emotional distress, kinesophobia, or inadequate response to prior treatments
- Capacity to provide informed consent and complete questionnaires
You will not qualify if you...
- Acute pain conditions (duration <3 months)
- Severe psychiatric or cognitive impairment
- Uncontrolled vertigo, epilepsy, or major visual/auditory impairments
- Conditions contraindicating use of VR equipment
- Inability to attend scheduled sessions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Primary Care Progrès-Raval
Badalona, Barcelona, Spain, 08912
Actively Recruiting
2
Primary Care Center Apenins-Montigalà
Badalona, Barcelona, Spain, 08917
Actively Recruiting
3
Primary Care Center Morera-Pomar
Badalona, Barcelona, Spain
Actively Recruiting
4
CAP Montgat- Dr Jardi
Montgat, Barcelona, Spain
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here